Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Complex Percutaneous Coronary Intervention Market by Stents (Drug-Eluting Stents (DES), Bare Metal Stents, Bioresorbable Stents) and by Surgery (Percutaneous Coronary Intervention (PCI), Transcatheter Aortic Valve Implantation (TAVI/TAVR), Trans-Mitral Valve Implantation (TMVR)): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03631

Pages: NA

Charts: NA

Tables: NA

Percutaneous coronary intervention (PCI) is a non-surgical procedure in which a catheter or a stent is used to open narrowed blood vessels which are blocked by deposition of plaque. It is used to improve blood flow and decrease heart-related chest pain improving the patients condition.

Rise in incidences of heart diseases, diabetes, and coronary artery disease, development of advanced stents, and introduction of cost effective intervention devices drive the market for complex percutaneous coronary intervention (PCI). However, low number of heart specialty hospitals and limited availability of heart surgeons restrain the market growth. Moreover, introduction of advanced technologies within the percutaneous coronary intervention such as advanced silicone and polymer implants in the emerging nations such as China, Brazil, and India create opportunities for the market growth during the forecast period.

The complex percutaneous coronary intervention market is segmented on the basis of types of stents, surgery, and region. On the basis of stents, it is divided into drug-eluting stents (DES), bare metal stents, and bioresorbable stents. On the basis of surgery, it is classified into percutaneous coronary intervention (PCI), transcatheter aortic valve implantation (TAVI/TAVR), and trans-mitral valve implantation (TMVR). By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players in the market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B. Braun Melsungen AG, Biosensors International Group, Ltd., Biotronik SE & Co. KG, Terumo Corporation, Johnson & Johnson, Getinge AB, and St. Jude Medical.

Key Benefits

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps understand various types of surgeries used for the treatment of coronary intervention.
  • Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

 Key Market Segments

  • By Stents
    • Drug-Eluting Stents (DES)
    • Bare Metal Stents
    • Bioresorbable Stents
  • By Surgery
    • Percutaneous Coronary Intervention (PCI)
    • Transcatheter Aortic Valve Implantation (TAVI/TAVR)
    • Trans-Mitral Valve Implantation (TMVR)
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Medtronic plc,
  • Biosensors International Group, Ltd.,
  • St. Jude Medical.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG,
  • Getinge AB,
  • Terumo Corporation,
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Johnson & Johnson,

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY STENTS

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Stents

    • 4.2. Drug-Eluting Stents (DES)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Bare Metal Stents

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Bioresorbable Stents

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY SURGERY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Surgery

    • 5.2. Percutaneous Coronary Intervention (PCI)

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Transcatheter Aortic Valve Implantation (TAVI/TAVR)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Trans-Mitral Valve Implantation (TMVR)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Stents

      • 6.2.3. Market Size and Forecast, By Surgery

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Complex Percutaneous Coronary Intervention Market

        • 6.2.5.1. Market Size and Forecast, By Stents
        • 6.2.5.2. Market Size and Forecast, By Surgery

      • 6.2.6. Canada Complex Percutaneous Coronary Intervention Market

        • 6.2.6.1. Market Size and Forecast, By Stents
        • 6.2.6.2. Market Size and Forecast, By Surgery

      • 6.2.7. Mexico Complex Percutaneous Coronary Intervention Market

        • 6.2.7.1. Market Size and Forecast, By Stents
        • 6.2.7.2. Market Size and Forecast, By Surgery

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Stents

      • 6.3.3. Market Size and Forecast, By Surgery

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Complex Percutaneous Coronary Intervention Market

        • 6.3.5.1. Market Size and Forecast, By Stents
        • 6.3.5.2. Market Size and Forecast, By Surgery

      • 6.3.6. Germany Complex Percutaneous Coronary Intervention Market

        • 6.3.6.1. Market Size and Forecast, By Stents
        • 6.3.6.2. Market Size and Forecast, By Surgery

      • 6.3.7. Italy Complex Percutaneous Coronary Intervention Market

        • 6.3.7.1. Market Size and Forecast, By Stents
        • 6.3.7.2. Market Size and Forecast, By Surgery

      • 6.3.8. Spain Complex Percutaneous Coronary Intervention Market

        • 6.3.8.1. Market Size and Forecast, By Stents
        • 6.3.8.2. Market Size and Forecast, By Surgery

      • 6.3.9. UK Complex Percutaneous Coronary Intervention Market

        • 6.3.9.1. Market Size and Forecast, By Stents
        • 6.3.9.2. Market Size and Forecast, By Surgery

      • 6.3.10. Russia Complex Percutaneous Coronary Intervention Market

        • 6.3.10.1. Market Size and Forecast, By Stents
        • 6.3.10.2. Market Size and Forecast, By Surgery

      • 6.3.11. Rest Of Europe Complex Percutaneous Coronary Intervention Market

        • 6.3.11.1. Market Size and Forecast, By Stents
        • 6.3.11.2. Market Size and Forecast, By Surgery

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Stents

      • 6.4.3. Market Size and Forecast, By Surgery

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Complex Percutaneous Coronary Intervention Market

        • 6.4.5.1. Market Size and Forecast, By Stents
        • 6.4.5.2. Market Size and Forecast, By Surgery

      • 6.4.6. Japan Complex Percutaneous Coronary Intervention Market

        • 6.4.6.1. Market Size and Forecast, By Stents
        • 6.4.6.2. Market Size and Forecast, By Surgery

      • 6.4.7. India Complex Percutaneous Coronary Intervention Market

        • 6.4.7.1. Market Size and Forecast, By Stents
        • 6.4.7.2. Market Size and Forecast, By Surgery

      • 6.4.8. South Korea Complex Percutaneous Coronary Intervention Market

        • 6.4.8.1. Market Size and Forecast, By Stents
        • 6.4.8.2. Market Size and Forecast, By Surgery

      • 6.4.9. Australia Complex Percutaneous Coronary Intervention Market

        • 6.4.9.1. Market Size and Forecast, By Stents
        • 6.4.9.2. Market Size and Forecast, By Surgery

      • 6.4.10. Thailand Complex Percutaneous Coronary Intervention Market

        • 6.4.10.1. Market Size and Forecast, By Stents
        • 6.4.10.2. Market Size and Forecast, By Surgery

      • 6.4.11. Malaysia Complex Percutaneous Coronary Intervention Market

        • 6.4.11.1. Market Size and Forecast, By Stents
        • 6.4.11.2. Market Size and Forecast, By Surgery

      • 6.4.12. Indonesia Complex Percutaneous Coronary Intervention Market

        • 6.4.12.1. Market Size and Forecast, By Stents
        • 6.4.12.2. Market Size and Forecast, By Surgery

      • 6.4.13. Rest of Asia Pacific Complex Percutaneous Coronary Intervention Market

        • 6.4.13.1. Market Size and Forecast, By Stents
        • 6.4.13.2. Market Size and Forecast, By Surgery

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Stents

      • 6.5.3. Market Size and Forecast, By Surgery

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Complex Percutaneous Coronary Intervention Market

        • 6.5.5.1. Market Size and Forecast, By Stents
        • 6.5.5.2. Market Size and Forecast, By Surgery

      • 6.5.6. South Africa Complex Percutaneous Coronary Intervention Market

        • 6.5.6.1. Market Size and Forecast, By Stents
        • 6.5.6.2. Market Size and Forecast, By Surgery

      • 6.5.7. Saudi Arabia Complex Percutaneous Coronary Intervention Market

        • 6.5.7.1. Market Size and Forecast, By Stents
        • 6.5.7.2. Market Size and Forecast, By Surgery

      • 6.5.8. UAE Complex Percutaneous Coronary Intervention Market

        • 6.5.8.1. Market Size and Forecast, By Stents
        • 6.5.8.2. Market Size and Forecast, By Surgery

      • 6.5.9. Argentina Complex Percutaneous Coronary Intervention Market

        • 6.5.9.1. Market Size and Forecast, By Stents
        • 6.5.9.2. Market Size and Forecast, By Surgery

      • 6.5.10. Rest of LAMEA Complex Percutaneous Coronary Intervention Market

        • 6.5.10.1. Market Size and Forecast, By Stents
        • 6.5.10.2. Market Size and Forecast, By Surgery

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott Laboratories

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Medtronic Plc,

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Boston Scientific Corporation

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. B. Braun Melsungen AG

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Biosensors International Group, Ltd.,

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Biotronik SE And Co. KG,

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Terumo Corporation,

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Johnson And Johnson,

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Getinge AB,

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. St. Jude Medical.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR DRUG-ELUTING STENTS (DES), BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BARE METAL STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BIORESORBABLE STENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION (PCI), BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI/TAVR), BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANS-MITRAL VALVE IMPLANTATION (TMVR), BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 13. U.S. COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 14. U.S. COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 15. CANADA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 16. CANADA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 18. MEXICO COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 23. FRANCE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 25. GERMANY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 26. ITALY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 27. ITALY COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 29. SPAIN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 30. UK COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 31. UK COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 33. RUSSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 35. REST OF EUROPE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 39. CHINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 40. CHINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 42. JAPAN COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 43. INDIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 44. INDIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 46. SOUTH KOREA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 48. AUSTRALIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 50. THAILAND COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 52. MALAYSIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 54. INDONESIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 56. REST OF ASIA PACIFIC COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 61. BRAZIL COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 63. SOUTH AFRICA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 65. SAUDI ARABIA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 66. UAE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 67. UAE COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 69. ARGENTINA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY STENTS, 2025-2033 ($MILLION)
  • TABLE 71. REST OF LAMEA COMPLEX PERCUTANEOUS CORONARY INTERVENTION, BY SURGERY, 2025-2033 ($MILLION)
  • TABLE 72. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 73. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 74. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 75. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 76. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 77. MEDTRONIC PLC,: KEY EXECUTIVES
  • TABLE 78. MEDTRONIC PLC,: COMPANY SNAPSHOT
  • TABLE 79. MEDTRONIC PLC,: OPERATING SEGMENTS
  • TABLE 80. MEDTRONIC PLC,: PRODUCT PORTFOLIO
  • TABLE 81. MEDTRONIC PLC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 83. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 84. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 86. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 88. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 89. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 90. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 91. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. BIOSENSORS INTERNATIONAL GROUP, LTD.,: KEY EXECUTIVES
  • TABLE 93. BIOSENSORS INTERNATIONAL GROUP, LTD.,: COMPANY SNAPSHOT
  • TABLE 94. BIOSENSORS INTERNATIONAL GROUP, LTD.,: OPERATING SEGMENTS
  • TABLE 95. BIOSENSORS INTERNATIONAL GROUP, LTD.,: PRODUCT PORTFOLIO
  • TABLE 96. BIOSENSORS INTERNATIONAL GROUP, LTD.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. BIOTRONIK SE AND CO. KG,: KEY EXECUTIVES
  • TABLE 98. BIOTRONIK SE AND CO. KG,: COMPANY SNAPSHOT
  • TABLE 99. BIOTRONIK SE AND CO. KG,: OPERATING SEGMENTS
  • TABLE 100. BIOTRONIK SE AND CO. KG,: PRODUCT PORTFOLIO
  • TABLE 101. BIOTRONIK SE AND CO. KG,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. TERUMO CORPORATION,: KEY EXECUTIVES
  • TABLE 103. TERUMO CORPORATION,: COMPANY SNAPSHOT
  • TABLE 104. TERUMO CORPORATION,: OPERATING SEGMENTS
  • TABLE 105. TERUMO CORPORATION,: PRODUCT PORTFOLIO
  • TABLE 106. TERUMO CORPORATION,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. JOHNSON AND JOHNSON,: KEY EXECUTIVES
  • TABLE 108. JOHNSON AND JOHNSON,: COMPANY SNAPSHOT
  • TABLE 109. JOHNSON AND JOHNSON,: OPERATING SEGMENTS
  • TABLE 110. JOHNSON AND JOHNSON,: PRODUCT PORTFOLIO
  • TABLE 111. JOHNSON AND JOHNSON,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. GETINGE AB,: KEY EXECUTIVES
  • TABLE 113. GETINGE AB,: COMPANY SNAPSHOT
  • TABLE 114. GETINGE AB,: OPERATING SEGMENTS
  • TABLE 115. GETINGE AB,: PRODUCT PORTFOLIO
  • TABLE 116. GETINGE AB,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ST. JUDE MEDICAL.: KEY EXECUTIVES
  • TABLE 118. ST. JUDE MEDICAL.: COMPANY SNAPSHOT
  • TABLE 119. ST. JUDE MEDICAL.: OPERATING SEGMENTS
  • TABLE 120. ST. JUDE MEDICAL.: PRODUCT PORTFOLIO
  • TABLE 121. ST. JUDE MEDICAL.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 3. SEGMENTATION COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCOMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 11. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION, BY BY STENTS
  • FIGURE 12. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR DRUG-ELUTING STENTS (DES), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BARE METAL STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR BIORESORBABLE STENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET SEGMENTATION, BY BY SURGERY
  • FIGURE 16. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR PERCUTANEOUS CORONARY INTERVENTION (PCI), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI/TAVR), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET FOR TRANS-MITRAL VALVE IMPLANTATION (TMVR), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 21. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 22. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 23. COMPETITIVE DASHBOARD
  • FIGURE 24. COMPETITIVE HEATMAP: COMPLEX PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 25. TOP PLAYER POSITIONING, 2024
  • FIGURE 26. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 27. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 28. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 29. MEDTRONIC PLC,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 30. MEDTRONIC PLC,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 31. MEDTRONIC PLC,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 32. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. B. BRAUN MELSUNGEN AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. BIOSENSORS INTERNATIONAL GROUP, LTD.,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. BIOSENSORS INTERNATIONAL GROUP, LTD.,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. BIOSENSORS INTERNATIONAL GROUP, LTD.,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. BIOTRONIK SE AND CO. KG,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. BIOTRONIK SE AND CO. KG,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. BIOTRONIK SE AND CO. KG,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. TERUMO CORPORATION,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. TERUMO CORPORATION,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. TERUMO CORPORATION,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. JOHNSON AND JOHNSON,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. JOHNSON AND JOHNSON,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. JOHNSON AND JOHNSON,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. GETINGE AB,: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. GETINGE AB,: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. GETINGE AB,: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. ST. JUDE MEDICAL.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. ST. JUDE MEDICAL.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. ST. JUDE MEDICAL.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Complex Percutaneous Coronary Intervention Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved